BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2548435)

  • 1. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
    Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
    Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
    Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA
    Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
    Zhang XK; Huang DP; Qiu DK; Chiu JF
    Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras oncogene p21 expression in hepatocellular carcinoma.
    Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
    J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
    Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
    Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
    Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
    Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of expression of p21 and c-myc protein in hepatocellular carcinoma with pericarcinomatous liver tissue].
    Feng D; Cheng R; Yan Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):310-2. PubMed ID: 9868083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
    Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
    Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
    Wu B; Wang M; You W; Yang S
    Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical localization of p21 ras gene product in human hepatoma cell lines and corresponding tumors in athymic mice.
    Matarazzo M; Faraggiana T; Donato MF; Paronetto F
    J Exp Pathol; 1987; 3(3):305-15. PubMed ID: 2835467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
    Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the expression of oncogene mRNA in hepatocellular carcinoma using in situ hybridization technique].
    Hayashi D
    Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):814-22. PubMed ID: 7830708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.